Stock Rich List
Nasdaq: MLYS

Mineralys Therapeutics insiders

The officers, directors and 10% owners of Mineralys Therapeutics, Inc. who hold the most stock, valued at the live MLYS price.

$14.16
MLYS today +$380K (+2.76%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
2
Their MLYS stock
$119M
Market value
$1.25B
Held by ranked insiders
9.53%

Insiders by value of MLYS holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Brian Taylor SlingsbyDirector7,910,038$112M8.93%1383rd
2Jon CongletonChief Executive Officer528,621$7.5M0.60%10851st

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Mineralys Therapeutics; see each profile for the filing.